DE60034460D1 - Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe - Google Patents

Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Info

Publication number
DE60034460D1
DE60034460D1 DE60034460T DE60034460T DE60034460D1 DE 60034460 D1 DE60034460 D1 DE 60034460D1 DE 60034460 T DE60034460 T DE 60034460T DE 60034460 T DE60034460 T DE 60034460T DE 60034460 D1 DE60034460 D1 DE 60034460D1
Authority
DE
Germany
Prior art keywords
vaccines
trehalosis
procaryotic cells
producing
producing procaryotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034460T
Other languages
English (en)
Other versions
DE60034460T2 (de
Inventor
Camilo Anthony Colaco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunobiology Ltd
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of DE60034460D1 publication Critical patent/DE60034460D1/de
Publication of DE60034460T2 publication Critical patent/DE60034460T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60034460T 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe Expired - Lifetime DE60034460T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9919732.9A GB9919732D0 (en) 1999-08-19 1999-08-19 Trehalose producing cells as vaccines
GB9919732 1999-08-19
PCT/GB2000/003223 WO2001013942A2 (en) 1999-08-19 2000-08-18 Trehalose producing prokaryotic cells as vaccines

Publications (2)

Publication Number Publication Date
DE60034460D1 true DE60034460D1 (de) 2007-05-31
DE60034460T2 DE60034460T2 (de) 2008-01-03

Family

ID=10859499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034460T Expired - Lifetime DE60034460T2 (de) 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Country Status (10)

Country Link
US (1) US20070243200A1 (de)
EP (1) EP1204420B1 (de)
AT (1) ATE359811T1 (de)
AU (1) AU6709500A (de)
DE (1) DE60034460T2 (de)
DK (1) DK1204420T3 (de)
ES (1) ES2286033T3 (de)
GB (1) GB9919732D0 (de)
PT (1) PT1204420E (de)
WO (1) WO2001013942A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8733289B2 (en) * 2008-04-07 2014-05-27 Rich Products Corporation Method for preparing edible aquatic animals for storage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312909A (en) * 1990-03-28 1994-05-17 Gist Brocades, N.V. Recombinant DNA encoding neutral trehalase
US5422254A (en) * 1992-02-14 1995-06-06 Oy Alko Ab Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby

Also Published As

Publication number Publication date
EP1204420B1 (de) 2007-04-18
PT1204420E (pt) 2007-07-20
WO2001013942A2 (en) 2001-03-01
EP1204420A2 (de) 2002-05-15
US20070243200A1 (en) 2007-10-18
GB9919732D0 (en) 1999-10-20
DK1204420T3 (da) 2007-09-17
DE60034460T2 (de) 2008-01-03
WO2001013942A3 (en) 2001-09-20
ATE359811T1 (de) 2007-05-15
ES2286033T3 (es) 2007-12-01
AU6709500A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
MY133377A (en) Anti-il-12 antibodies, compositions, methods and uses
DE69824013D1 (de) Impfstoff gegen hpv
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
WO2004002417A3 (en) Mammalian ch1 deleted mimetibodies, compositions, methods and uses
TR201816277T4 (tr) Çapraz-tür-spesifik bağlama alanı.
MXPA05009682A (es) Metodos de radiofluorinacion de vectores biologicamente activos.
IL196900A (en) Autologous T cell vaccine compositions
PL1668001T3 (pl) Podstawione heteroarylobenzofuranowe kwasy
PT1083903E (pt) Indenopirrolocarbazoles em ponte
DK1278868T3 (da) Muteret form af arginindeiminase
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
ATE321853T1 (de) Humanische pellino-polypeptide
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
DE60034460D1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition